Results 181 to 190 of about 9,259 (230)

Haemophilia B is clinically less severe than haemophilia A: further evidence. [PDF]

Blood Transfus, 2018
Franchini M, Mannucci PM.
europepmc   +1 more source

Pattern of use and clinical outcomes with rIX‐FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real‐world study [PDF]

Paola Giordano, Berardino Pollio, Gianluca Sottilotta, Chiara Biasoli, Filomena Daniele, Raimondo De Cristofaro, Flora Peyvandi, Maria Rosaria Villa, Giancarlo Castaman   +8 more
openalex   +1 more source

Current and emerging gene therapies for haemophilia A and B [PDF]

Radosław Kaczmarek, Wolfgang Miesbach, Margareth C. Ozelo, Pratima Chowdary   +3 more
openalex   +1 more source

Switching From Standard to Extended Half-Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland. [PDF]

Haemophilia
Koivusalo M, Szanto T, Kovalainen T, Vesikansa A, Laine O, Partanen A, Siitonen T, Vesanen M, Mehtälä J, Sarnesto N, Haapkylä J, Lehtinen AE, Lassila R.   +12 more
europepmc   +1 more source

Normal Haemostasis, Inherited Bleeding Disorders and Surgery: What Does the Anaesthesiologist Need to Know? [PDF]

Medicina (Kaunas)
Ștefan M, Filipescu D, Predoi C, Văleanu L, Andrei Ș, Tomescu D.   +5 more
europepmc   +1 more source

Altuvoct: Innovative Medicinal Products Benefit from Innovative Approaches to Regulatory Assessment. [PDF]

Life (Basel)
Kerwash E, Malamatari M, Johnston JD.
europepmc   +1 more source

Experiences and Needs Regarding Information Provision in Children With Haemophilia: A Qualitative Study on Caregivers' and Healthcare Providers' Perspectives. [PDF]

Haemophilia
Mussert CMA, Kamminga NCW, van Hoorn ES, Eekelaar TM, Dehli SR, van der Velden-van 't Hoff C, Andeweg S, Reitsma SH, Nooteboom ACM, Diekstra A, Albayrak A, Cnossen MH, SYMPHONY consortium.   +12 more
europepmc   +1 more source

Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE‐B trial 2 years after gene therapy

Robbin Itzler, Tyler W. Buckner, Frank W.G. Leebeek, Joel Miller, Michael Recht, Douglass Drelich, Paul E. Monahan, Steven W. Pipe   +7 more
openalex   +1 more source

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review. [PDF]

Hematol Transfus Cell Ther
Araujo IO, Suassuna LF, Dos Santos IL, Rodrigues DOW.   +3 more
europepmc   +1 more source

Subgaleal hematoma in hereditary coagulopathy haemophilia B: a case report

Vivek Arora, Kapil Sharma, Akanksha Sharma, Madhvi Joshi   +3 more
openalex   +1 more source